Actively Recruiting

Phase Not Applicable
Age: 40Years - 65Years
MALE
Healthy Volunteers
NCT07561203

Effect of Collavant® n2 in Healthy Male Adults With Exercise-induced Joint Discomfort.

Led by Bioiberica · Updated on 2026-05-13

80

Participants Needed

1

Research Sites

42 weeks

Total Duration

On this page

Sponsors

B

Bioiberica

Lead Sponsor

U

Universidad Politecnica de Madrid

Collaborating Sponsor

AI-Summary

What this Trial Is About

The present clinical study has been designed to evaluate the effect of Collavant® n2 at a daily dose of 40 mg on joint function and performance in healthy, amateur male runners with exercise-induced knee discomfort.

CONDITIONS

Official Title

Effect of Collavant® n2 in Healthy Male Adults With Exercise-induced Joint Discomfort.

Who Can Participate

Age: 40Years - 65Years
MALE
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Healthy physically active male amateur runners aged 40 to 65 years
  • Regular training for at least 150 minutes per week over a minimum of 3 months, spread over 2 or more sessions weekly
  • Self-reported knee discomfort after activity with a minimum score of 20 mm on the Visual Analog Scale, persistent for at least 2 weeks
  • Willingness to avoid starting new dietary supplements targeting joint benefits during the study; stable intake of other supplements (except collagen) if used consistently for at least 6 months prior
  • Use of individual devices with GPS to monitor training
  • Signed informed consent
Not Eligible

You will not qualify if you...

  • Diagnosis of knee osteoarthritis or any knee pathology or previous knee surgery
  • Hypersensitivity to any component of the supplement or placebo
  • Chronic use of analgesic or anti-inflammatory drugs including NSAIDs and corticosteroids
  • Current treatment with any type of collagen supplement
  • Treatment with probiotics or antibiotics
  • Inability to maintain training for the next 24 weeks
  • Following a vegan diet

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Universidad Politecnica de Madrid

Madrid, Madrid, Spain, 28040

Actively Recruiting

Loading map...

Research Team

M

Mónica García-López, Doctor

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

OTHER

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here